Advertisement
Home »

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.

Jan 08, 2024

ABOUT THE EXPERTS

  • Francisco J Martinez

    Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.

    Michael White

    Infectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, Paris, France.

    Micheline Guillotte-Blisnick

    Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.

    Christèle Huon

    Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France.

    Alix Boucharlat

    Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France.

    Fabrice Agou

    Chemogenomic and Biological Screening Core Facility, C2RT, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France.

    Patrick England

    Molecular Biophysics Facility, CNRS UMR 3528, Institut Pasteur, Paris, France.

    Jean Popovici

    Malaria Reasearch Unit, Institut Pasteur du Cambodge, Pnom Penh, Cambodia.

    Mimi M Hou

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    Sarah E Silk

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    Jordan R Barrett

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    Carolyn M Nielsen

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    Jenny M Reimer

    Novavax AB, Kungsgatan 109, SE-753 18, Uppsala, Sweden.

    Paushali Mukherjee

    Multi-Vaccines Development Program, ICGEB Campus, New Delhi, India.

    Virander S Chauhan

    International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.

    Angela M Minassian

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    NIHR Oxford Biomedical Research Centre, Oxford, UK.

    Simon J Draper

    Department of Biochemistry, University of Oxford, Oxford, OX1 3QU, UK.

    The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK.

    Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, OX1 3QU, UK.

    NIHR Oxford Biomedical Research Centre, Oxford, UK.

    Chetan E Chitnis

    Unité de Biologie de Plasmodium et Vaccins, Institut Pasteur, Université Paris Cité, Paris, France. chetan.chitnis@pasteur.fr.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement